Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
Public ClinicalTrials.gov record NCT00097812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Assess the Safety, Tolerability, and Efficacy of Switching Patients Currently on Oral Bisphosphonate to Zoledronic Acid
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess bone mineral density in patients switching from an oral bisphosphonate to zoledronic acid, compared to those staying on the oral bisphosphonate.
Study identification
- NCT ID
- NCT00097812
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 79 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2004 (Type not available)
- Primary completion
- Dec 2005 (Actual)
- Completion
- Dec 2005 (Actual)
- Last update posted
- Apr 27, 2012
2004 – 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Permanente Medical Group | Santa Rosa | California | 95403 | — |
| Colorado Center for Bone Research | Lakewood | Colorado | 80227 | — |
| Florida Medical Research Institute | Gainsville | Florida | 32605 | — |
| Radiant Research | Stuart | Florida | 34996 | — |
| University of Kansas School of Medicine/ Division of Endocrinology | Kansas City | Kansas | 66160 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01610 | — |
| Arthritis Center of Nebraska | Lincoln | Nebraska | 68516 | — |
| Creighton University Osteoporosis Research Center | Omaha | Nebraska | 68131 | — |
| Oregon Osteoporosis Center | Portland | Oregon | 97213 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Radiant Research | Wyomissing | Pennsylvania | 19610 | — |
| Puget Sound Osteoporosis Center | Seattle | Washington | 98144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00097812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00097812 live on ClinicalTrials.gov.